Vir Biotechnology Inc

NASDAQ:VIR   3:59:56 PM EDT
38.70
0.00 (0.00%)
: $38.70 0.00 (0.00%)
Products, Expansion

Vir Biotechnology Launches New Antibody Research Initiative Aimed At Functional Cure For HIV And Prevention Of Malaria

Published: 01/13/2022 14:40 GMT
Vir Biotechnology Inc (VIR) - Vir Biotechnology Launches New Antibody Research Initiative Aimed at a Functional Cure for Hiv and Prevention of Malaria.
Vir Biotechnology Inc - Announced an Expansion of Its Partnership With Bill & Melinda Gates Foundation.
Vir Biotechnology - Vaccinal Antibody Concept Will Now Be Used to Address Other Infectious Diseases With High Impact in Low & Middle-income Countries.
Vir Biotechnology Inc - to Support Effort, Gates Foundation Has Committed a $40 Million Equity Investment and a $10 Million Grant.
Vir Biotechnology Inc - Program-related Equity Investment by Gates Foundation is Being Made Through Its $2.5 Billion Strategic Investment Fund.